Compare ETFs: SURI
SURI
Comparison
Average Return
| Symbol | Year-to-date | 1 Year | 5 Years | 10 Years | Inception |
|---|---|---|---|---|---|
| SURI | 24.24% | -15.94% | - | - | 1.61% |
Top 25 Holdings
| SURI - Simplify Propel Opportunities ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | PAGP | Plains GP Holdings, L.P. | 30.79% |
| 2 | AKRO | Akero Therapeutics, Inc. | 10.53% |
| 3 | MIST | Milestone Pharmaceuticals Inc. | 8.93% |
| 4 | PHAT | Phathom Pharmaceuticals, Inc. | 6.35% |
| 5 | ACHV | Achieve Life Sciences, Inc. | 6.26% |
| 6 | VRDN | Viridian Therapeutics, Inc. | 4.41% |
| 7 | ABEO | Abeona Therapeutics Inc. | 3.41% |
| 8 | DCTH | Delcath Systems, Inc. | 3.21% |
| 9 | CLDX | Celldex Therapeutics, Inc. | 2.98% |
| 10 | OCS | Oculis Holding AG | 2.53% |
| 11 | NKTR | Nektar Therapeutics | 2.18% |
| 12 | n/a | WTS - MILESTONE PHARMACEUTICALS INC SERIES A | 2.13% |
| 13 | CMPS | COMPASS Pathways plc | 2.00% |
| 14 | IVA | Inventiva S.A. | 1.81% |
| 15 | APLT | Applied Therapeutics, Inc. | 1.54% |
| 16 | Cash | Cash | 1.33% |
| 17 | n/a | ACHIEVE LIFE SCIENCES I WTS 30JUN30 | 1.25% |
| 18 | n/a | WTS - MILESTONE PHARMACEUTICALS INC SERIES B | 1.21% |
| 19 | TELSAT.5.625 12.06.26 144A | TELSAT 5.625 12/06/26 144A Corp | 1.00% |
| 20 | SABS | SAB Biotherapeutics, Inc. | 0.92% |
| 21 | n/a | WTS - QUOIN PHARMACEUTICALS LTD - Pre-funded | 0.91% |
| 22 | ATHA | Athira Pharma, Inc. | 0.88% |
| 23 | JSPR | Jasper Therapeutics, Inc. | 0.70% |
| 24 | n/a | WTS - QUOIN PHARMACEUTICALS LTD - Series H | 0.49% |
| 25 | TCRX | TScan Therapeutics, Inc. | 0.45% |
| View SURI holdings | |||